Published in J Physiol on October 10, 2003
Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry (2006) 2.53
Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology (Berl) (2010) 1.31
Aromatic residues at position 55 of rat alpha7 nicotinic acetylcholine receptors are critical for maintaining rapid desensitization. J Physiol (2007) 1.11
Effects of cigarette smoking and abstinence on Stroop task performance. Psychopharmacology (Berl) (2007) 1.06
Modeling multiple species of nicotine and deschloroepibatidine interacting with alpha4beta2 nicotinic acetylcholine receptor: from microscopic binding to phenomenological binding affinity. J Am Chem Soc (2005) 1.05
The neuronal nicotinic alpha4beta2 receptor has a high maximal probability of being open. Br J Pharmacol (2010) 1.05
Effect of cigarette smoking on prefrontal cortical function in nondeprived smokers performing the Stroop Task. Neuropsychopharmacology (2006) 1.02
X-ray structure of the human α4β2 nicotinic receptor. Nature (2016) 0.97
Biological basis for the co-morbidity between smoking and mood disorders. J Dual Diagn (2009) 0.96
86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization. Biochem Pharmacol (2010) 0.95
VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors. J Pharmacol Exp Ther (2012) 0.95
Agonist-dependence of recovery from desensitization of P2X(3) receptors provides a novel and sensitive approach for their rapid up or downregulation. Br J Pharmacol (2004) 0.95
Activation of heteroliganded mouse muscle nicotinic receptors. J Physiol (2005) 0.92
Lipid rafts control P2X3 receptor distribution and function in trigeminal sensory neurons of a transgenic migraine mouse model. Mol Pain (2011) 0.92
Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype. Nicotine Tob Res (2012) 0.91
Nicotinic acetylcholine receptors mediate lung cancer growth. Front Physiol (2013) 0.91
The nicotinic acetylcholine receptor as a target for antidepressant drug development. ScientificWorldJournal (2012) 0.90
Complex relationships of nicotinic receptor actions and cognitive functions. Biochem Pharmacol (2013) 0.88
Increased nicotinic receptor desensitization in hypoglossal motor neurons following chronic developmental nicotine exposure. J Neurophysiol (2011) 0.87
The additional ACh binding site at the α4(+)/α4(-) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitization. Br J Pharmacol (2013) 0.85
Desensitization of alpha7 nicotinic receptor is governed by coupling strength relative to gate tightness. J Biol Chem (2011) 0.85
Modulation of recombinant, α2*, α3* or α4*-nicotinic acetylcholine receptor (nAChR) function by nAChR β3 subunits. J Neurochem (2012) 0.85
Effects of sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, on body temperature regulation in mice and rats. Eur J Pharmacol (2012) 0.83
Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Br J Pharmacol (2005) 0.82
Improvement of attentional function with antagonism of nicotinic receptors in female rats. Eur J Pharmacol (2013) 0.82
Desensitization of neuronal nicotinic receptors of human neuroblastoma SH-SY5Y cells during short or long exposure to nicotine. Br J Pharmacol (2005) 0.81
Mechanisms of Inhibition and Potentiation of α4β2 Nicotinic Acetylcholine Receptors by Members of the Ly6 Protein Family. J Biol Chem (2015) 0.80
Computational neural network analysis of the affinity of N-n-alkylnicotinium salts for the alpha4beta2* nicotinic acetylcholine receptor. J Enzyme Inhib Med Chem (2009) 0.80
Pharmacological identification of cholinergic receptor subtypes on Drosophila melanogaster larval heart. J Comp Physiol B (2015) 0.79
PKCε phosphorylates α4β2 nicotinic ACh receptors and promotes recovery from desensitization. Br J Pharmacol (2015) 0.79
Endogenous cholinergic inputs and local circuit mechanisms govern the phasic mesolimbic dopamine response to nicotine. PLoS Comput Biol (2013) 0.78
Functional characterization improves associations between rare non-synonymous variants in CHRNB4 and smoking behavior. PLoS One (2014) 0.77
Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias. Neurobiol Dis (2016) 0.77
Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP). Neuropharmacology (2015) 0.77
A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self-administration. Am J Addict (2013) 0.76
Agonist and antagonist effects of tobacco-related nitrosamines on human α4β2 nicotinic acetylcholine receptors. Front Pharmacol (2015) 0.76
Trapping of ivermectin by a pentameric ligand-gated ion channel upon open-to-closed isomerization. Sci Rep (2017) 0.75
Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia. Exp Neurol (2016) 0.75
A study of the desensitization produced by acetylcholine at the motor end-plate. J Physiol (1957) 15.07
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature (1998) 6.27
Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci (1995) 4.37
Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron (2002) 3.78
Presynaptic nicotinic ACh receptors. Trends Neurosci (1997) 3.31
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature (1995) 3.28
Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Mol Pharmacol (2003) 3.22
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol (1992) 3.20
Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron (2000) 3.08
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci (2001) 2.69
Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol (2002) 2.68
Desensitization of neuronal nicotinic receptors. J Neurobiol (2002) 2.49
Cognitive effects of nicotine. Biol Psychiatry (2001) 2.41
Cholinergic interneuron characteristics and nicotinic properties in the striatum. J Neurobiol (2002) 2.36
Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci (2003) 2.35
Desensitization at the frog neuromuscular junction: a biphasic process. J Physiol (1982) 2.31
Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport (2002) 2.28
Molecular and cellular aspects of nicotine abuse. Neuron (1996) 2.25
Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J Neurochem (1988) 2.24
Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron (2001) 2.23
Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. J Neurosci (2001) 2.15
Desensitization of mouse nicotinic acetylcholine receptor channels. A two-gate mechanism. J Gen Physiol (1998) 2.15
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature (1999) 2.13
Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav (2001) 2.07
Drug addiction: bad habits add up. Nature (1999) 1.97
Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol Pharmacol (1998) 1.97
Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci (1997) 1.79
Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology (2003) 1.74
Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res (1996) 1.66
Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin Pharmacol Ther (1997) 1.53
Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J Neurosci (1999) 1.49
Desensitization of the acetylcholine receptor of frog end-plates measured in a Vaseline-gap voltage clamp. J Physiol (1989) 1.48
Desensitization of acetylcholine receptors in BC3H-1 cells. Pflugers Arch (1992) 1.41
A method for making solution changes in the sub-millisecond range at the tip of a patch pipette. Pflugers Arch (1989) 1.41
Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study. J Neurosci (1996) 1.34
Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions. J Pharmacol Exp Ther (2002) 1.32
Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction. Drug Alcohol Depend (1999) 1.32
Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors. Neuropharmacology (2000) 1.26
Regulation of alpha4beta2 nicotinic receptor desensitization by calcium and protein kinase C. Mol Pharmacol (1999) 1.23
Long-term desensitization of nicotinic acetylcholine receptors is regulated via protein kinase A-mediated phosphorylation. J Neurosci (1998) 1.22
Neuronal nicotinic acetylcholine receptors are blocked by intracellular spermine in a voltage-dependent manner. J Neurosci (1998) 1.19
Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor. J Pharmacol Exp Ther (1996) 1.18
Two distinct kinetic phases of desensitization of acetylcholine receptors of clonal rat PC12 cells. J Physiol (1987) 1.13
Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol. Mol Pharmacol (2002) 1.12
Glutamate and GABA release are enhanced by different subtypes of presynaptic nicotinic receptors in the lateral geniculate nucleus. J Neurosci (1998) 1.02
Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism. Mol Pharmacol (1997) 1.02
The unusual nature of epibatidine responses at the alpha4beta2 nicotinic acetylcholine receptor. Neuropharmacology (2000) 1.02
Nicotinic receptors and hippocampal synaptic plasticity ... it's all in the timing. Trends Neurosci (2002) 1.01
Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking. Pharmacol Biochem Behav (2001) 0.95
Presynaptic ionotropic receptors. Curr Opin Neurobiol (1996) 0.95
Cytisine binds with similar affinity to nicotinic alpha4beta2 receptors on the cell surface and in homogenates. Brain Res (2003) 0.94
First and second transmembrane segments of alpha3, alpha4, beta2, and beta4 nicotinic acetylcholine receptor subunits influence the efficacy and potency of nicotine. Mol Pharmacol (2002) 0.93
Multiple components in the agonist concentration-response relationships of neuronal nicotinic acetylcholine receptors. J Neurosci Methods (2000) 0.92
Ligand binding and activation of rat nicotinic alpha4beta2 receptors stably expressed in HEK293 cells. Mol Pharmacol (1999) 0.92
Desensitization of nicotinic agonist-induced [3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists. J Pharmacol Exp Ther (1999) 0.90
Analgesic doses of intrathecal but not intravenous clonidine increase acetylcholine in cerebrospinal fluid in humans. Anesth Analg (1997) 0.83
Desensitization of embryonic nicotinic acetylcholine receptors expressed in Xenopus oocytes. Neurosci Lett (1993) 0.83
Uptake and regional distribution of (+)-(R)- and (-)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo. J Neural Transm Park Dis Dement Sect (1989) 0.81
Acetylcholine in human CSF: methodological considerations and levels in dementia of Alzheimer type. J Neural Transm (Vienna) (1998) 0.78
Neurosteroid access to the GABAA receptor. J Neurosci (2005) 1.95
Mechanisms of neurosteroid interactions with GABA(A) receptors. Pharmacol Ther (2007) 1.60
Neuroactive steroids have multiple actions to potentiate GABAA receptors. J Physiol (2004) 1.47
Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids. Mol Pharmacol (2008) 1.46
Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABAA receptor. Mol Pharmacol (2007) 1.33
Dual potentiating and inhibitory actions of a benz[e]indene neurosteroid analog on recombinant alpha1beta2gamma2 GABAA receptors. Mol Pharmacol (2006) 1.31
3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J Neurosci (2002) 1.18
Activation of GABA(A) receptors containing the alpha4 subunit by GABA and pentobarbital. J Physiol (2004) 1.18
Rare missense variants in CHRNB4 are associated with reduced risk of nicotine dependence. Hum Mol Genet (2011) 1.08
Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA-A receptor potentiation. J Physiol (2007) 1.07
Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor. Mol Pharmacol (2012) 1.05
Steroid interaction with a single potentiating site is sufficient to modulate GABA-A receptor function. Mol Pharmacol (2009) 1.04
Anticonvulsant and anesthetic effects of a fluorescent neurosteroid analog activated by visible light. Nat Neurosci (2007) 1.03
The cholinergic antagonist alpha-bungarotoxin also binds and blocks a subset of GABA receptors. Proc Natl Acad Sci U S A (2006) 1.02
Neuroactive steroids and human recombinant rho1 GABAC receptors. J Pharmacol Exp Ther (2007) 1.00
Activation and block of mouse muscle-type nicotinic receptors by tetraethylammonium. J Physiol (2003) 1.00
Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site. J Neurosci (2005) 0.96
Functional characterization of the α5(Asn398) variant associated with risk for nicotine dependence in the α3β4α5 nicotinic receptor. Mol Pharmacol (2011) 0.95
Activation and modulation of concatemeric GABA-A receptors expressed in human embryonic kidney cells. Mol Pharmacol (2009) 0.95
Cytisine binds with similar affinity to nicotinic alpha4beta2 receptors on the cell surface and in homogenates. Brain Res (2003) 0.94
A portable site: a binding element for 17β-estradiol can be placed on any subunit of a nicotinic α4β2 receptor. J Neurosci (2011) 0.94
Role of the agonist binding site in up-regulation of neuronal nicotinic alpha4beta2 receptors. Mol Pharmacol (2006) 0.93
Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors. J Biol Chem (2008) 0.93
Hydrogen bonding between the 17beta-substituent of a neurosteroid and the GABA(A) receptor is not obligatory for channel potentiation. Br J Pharmacol (2009) 0.93
Ethanol modulates the interaction of the endogenous neurosteroid allopregnanolone with the alpha1beta2gamma2L GABAA receptor. Mol Pharmacol (2006) 0.92
Enantiomers of neuroactive steroids support a specific interaction with the GABA-C receptor as the mechanism of steroid action. Mol Pharmacol (2006) 0.92
Characteristics of concatemeric GABA(A) receptors containing α4/δ subunits expressed in Xenopus oocytes. Br J Pharmacol (2012) 0.92
The influence of the membrane on neurosteroid actions at GABA(A) receptors. Psychoneuroendocrinology (2009) 0.91
Kinetic and structural determinants for GABA-A receptor potentiation by neuroactive steroids. Curr Neuropharmacol (2010) 0.90
Low doses of ethanol and a neuroactive steroid positively interact to modulate rat GABA(A) receptor function. J Physiol (2003) 0.89
Kinetic analysis of voltage-dependent potentiation and block of the glycine alpha 3 receptor by a neuroactive steroid analogue. J Physiol (2009) 0.88
The nicotinic α5 subunit can replace either an acetylcholine-binding or nonbinding subunit in the α4β2* neuronal nicotinic receptor. Mol Pharmacol (2013) 0.88
A synthetic 18-norsteroid distinguishes between two neuroactive steroid binding sites on GABAA receptors. J Pharmacol Exp Ther (2010) 0.87
Occupation of either site for the neurosteroid allopregnanolone potentiates the opening of the GABAA receptor induced from either transmitter binding site. Mol Pharmacol (2011) 0.86
Photoaffinity labeling the agonist binding domain of alpha4beta4 and alpha4beta2 neuronal nicotinic acetylcholine receptors with [(125)I]epibatidine and 5[(125)I]A-85380. Biochim Biophys Acta (2009) 0.85
Activation and block of the adult muscle-type nicotinic receptor by physostigmine: single-channel studies. Mol Pharmacol (2008) 0.85
Cis-regulatory variants affect CHRNA5 mRNA expression in populations of African and European ancestry. PLoS One (2013) 0.85
Site-specific fluorescence reveals distinct structural changes induced in the human rho 1 GABA receptor by inhibitory neurosteroids. Mol Pharmacol (2010) 0.84
Common polymorphisms in FMO1 are associated with nicotine dependence. Pharmacogenet Genomics (2011) 0.84
Pharmacology of structural changes at the GABA(A) receptor transmitter binding site. Br J Pharmacol (2011) 0.83
The benzodiazepine diazepam potentiates responses of α1β2γ2L γ-aminobutyric acid type A receptors activated by either γ-aminobutyric acid or allosteric agonists. Anesthesiology (2013) 0.82
A neurosteroid potentiation site can be moved among GABAA receptor subunits. J Physiol (2012) 0.80
Structural studies of the actions of anesthetic drugs on the γ-aminobutyric acid type A receptor. Anesthesiology (2011) 0.80
Energetic contributions to channel gating of residues in the muscle nicotinic receptor β1 subunit. PLoS One (2013) 0.78
Agonist-specific conformational changes in the α1-γ2 subunit interface of the GABA A receptor. Mol Pharmacol (2012) 0.76
Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol. Curr Neuropharmacol (2016) 0.75
Pharmacology: Unready for action. Nature (2008) 0.75
Inhibition of muscle acetylcholine receptors by nondepolarizing drugs: humans are not unique. Anesthesiology (2010) 0.75